MARSHALL WACE, LLP - ASSERTIO THERAPEUTICS INC ownership

ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 163 filers reported holding ASSERTIO THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ASSERTIO THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$613,000
-75.2%
942,564
-52.3%
0.01%
-64.7%
Q4 2019$2,470,000
+399.0%
1,976,052
+1276.7%
0.02%
+325.0%
Q2 2019$495,000
-93.8%
143,538
-90.9%
0.00%
-89.5%
Q1 2019$7,956,000
+459.9%
1,569,146
+298.8%
0.04%
+153.3%
Q4 2018$1,421,000393,4960.02%
Other shareholders
ASSERTIO THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 3,278,000$11,834,0000.90%
Senvest Management, LLC 2,124,393$7,669,0000.66%
DELTEC ASSET MANAGEMENT LLC 351,176$1,268,0000.35%
PERKINS CAPITAL MANAGEMENT INC 99,600$360,0000.28%
Matarin Capital Management, LLC 838,619$3,027,415,0000.24%
GLOBEFLEX CAPITAL L P 196,357$709,0000.17%
Opaleye Management Inc. 120,000$433,0000.16%
TSP Capital Management Group, LLC 49,175$178,0000.10%
Spark Investment Management LLC 373,609$1,348,0000.09%
Connor, Clark & Lunn Investment Management Ltd. 3,191,964$11,523,0000.08%
View complete list of ASSERTIO THERAPEUTICS INC shareholders